COVID-19 Induced Coagulopathy (CIC): Thrombotic Manifestations of Viral Infection
Original Article
[키워드] Abnormalities
abnormality
activated
acute lung injury
acute respiratory distress
acute respiratory syndrome
affected
age
alteration
ARDS
caused
Characteristics
CIC
Clinical finding
Coagulation
coagulation parameter
coagulation test
coagulative
Coagulopathy
consequence
coronavirus
Coronavirus disease 2019
COVID-19
COVID-19 infection
D-dimer
Degradation
develop
disease
Disseminated intravascular coagulation
dysfunction
early phase
Evidence
exhibiting
Fibrinogen levels
ICUs
Immunity
implication
incidence
increased mortality
induced
infected patient
Inflammation
initial
intensive care unit
involved
less
manifestation
manifested
Measures
multiple organs
overactive
Patient
patients
Platelet
Prophylaxis
proportion
Prothrombin time
protocol
Respiratory failure
respiratory tract
resulting
SARS-CoV-2
SARS-CoV-2 infected patient
severe COVID-19
severe infections
Stage
standard supportive care
syndrome
the disease
therapeutic
thromboembolic
thromboembolic complications
Thromboembolic event
thrombosis
venous
viral infection
with COVID-19
[DOI] 10.1055/s-0042-1744185 PMC 바로가기 [Article Type] Original Article
[DOI] 10.1055/s-0042-1744185 PMC 바로가기 [Article Type] Original Article